Sunshine Biopharma Inc. warrant
SBFMWStock
$0.04
Market Cap—
P/E—
Div yield—
Beta0.72
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-93.07%
Price vs S&P 500 (4W)-1.07%
VGM Score2.98
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SBFMWSunshine Biopharma Inc. warrant | — | — | F | $0.04 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Sunshine Biopharma is a pharmaceutical company with established operations in generic prescription drugs and OTC supplements, primarily in Canada. The company is advancing a proprietary drug development pipeline focused on oncology and infectious disease, including K1.1 mRNA for liver cancer and SBFM-PL4, a protease inhibitor for SARS-CoV-2. This dual approach combines steady revenue from existing products with potential growth from pipeline programs.